MX2016016301A - Procesos de siembra en serie y usos de los mismos. - Google Patents

Procesos de siembra en serie y usos de los mismos.

Info

Publication number
MX2016016301A
MX2016016301A MX2016016301A MX2016016301A MX2016016301A MX 2016016301 A MX2016016301 A MX 2016016301A MX 2016016301 A MX2016016301 A MX 2016016301A MX 2016016301 A MX2016016301 A MX 2016016301A MX 2016016301 A MX2016016301 A MX 2016016301A
Authority
MX
Mexico
Prior art keywords
same
seeding processes
serial
serial seeding
processes
Prior art date
Application number
MX2016016301A
Other languages
English (en)
Other versions
MX373323B (es
Inventor
Zhou Weichang
Wright Benjamin
Konstantinov Konstantin
BRUNINGHAUS Michael
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53477008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016016301(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of MX2016016301A publication Critical patent/MX2016016301A/es
Publication of MX373323B publication Critical patent/MX373323B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/28—Constructional details, e.g. recesses, hinges disposable or single use
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/58—Reaction vessels connected in series or in parallel
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16—Vibrating; Shaking; Tilting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/10—Perfusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0031—Serum-free culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

En la presente invención se proporcionan en la presente procesos de siembra en serie y métodos para producir una proteína recombinante que incluye el uso de estos procesos de siembra en serie.
MX2016016301A 2014-06-09 2015-06-08 Procesos de siembra en serie y usos de los mismos. MX373323B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462009553P 2014-06-09 2014-06-09
PCT/US2015/034709 WO2015191462A1 (en) 2014-06-09 2015-06-08 Seed train processes and uses thereof

Publications (2)

Publication Number Publication Date
MX2016016301A true MX2016016301A (es) 2017-04-06
MX373323B MX373323B (es) 2020-05-04

Family

ID=53477008

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016016301A MX373323B (es) 2014-06-09 2015-06-08 Procesos de siembra en serie y usos de los mismos.
MX2020004073A MX2020004073A (es) 2014-06-09 2016-12-08 Procesos de siembra en serie y usos de los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020004073A MX2020004073A (es) 2014-06-09 2016-12-08 Procesos de siembra en serie y usos de los mismos.

Country Status (18)

Country Link
US (2) US10570367B2 (es)
EP (3) EP3858983B1 (es)
JP (3) JP6784600B2 (es)
KR (2) KR102584375B1 (es)
CN (2) CN106574249B (es)
AU (3) AU2015274897B2 (es)
BR (1) BR112016028891B1 (es)
CA (1) CA2951551C (es)
CY (1) CY1122803T1 (es)
DK (1) DK3152299T3 (es)
ES (2) ES3043610T3 (es)
HU (1) HUE047683T2 (es)
IL (3) IL290096B2 (es)
MX (2) MX373323B (es)
RU (1) RU2694327C2 (es)
SG (1) SG11201610216UA (es)
TW (3) TW202246486A (es)
WO (1) WO2015191462A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014218715B2 (en) 2013-02-22 2019-12-12 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
MX367025B (es) 2013-02-22 2019-08-02 Genzyme Corp Metodos de cultivo por perfusion con microportadores y usos de los mismos.
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TW202246486A (zh) 2014-06-09 2022-12-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
MX383857B (es) 2014-12-22 2025-03-14 Genzyme Corp Métodos de cultivo de una célula de mamífero.
CA3001761A1 (en) * 2015-10-26 2017-05-04 Lonza Limited A manufacturing facility for the production of biopharmaceuticals
JP6973411B2 (ja) * 2016-12-22 2021-11-24 東亞合成株式会社 接着剤組成物並びにこれを用いたカバーレイフィルム、ボンディングシート、銅張積層板及び電磁波シールド材
WO2019055796A1 (en) * 2017-09-15 2019-03-21 Bristol-Myers Squibb Company ONLINE BIOMASS CAPACITY MONITORING DURING LARGE SCALE PRODUCTION OF POLYPEPTIDES OF INTEREST
TWI898645B (zh) * 2018-05-04 2025-09-21 美商健臻公司 灌注式細胞培養裝置
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
EP3650528A1 (en) 2018-11-08 2020-05-13 Aglaris Ltd Cell culture system and method
JP7365419B2 (ja) * 2019-01-25 2023-10-19 エンゼン・バイオサイエンシズ・リミテッド 治療用タンパク質を生産するための自動化統合連続システム及びバイオプロセス
BR112021014582A2 (pt) * 2019-02-15 2021-10-05 Just-Evotec Biologics, Inc. Sistemas, instalações e processos de biomanufatura automatizados
KR20220016480A (ko) * 2019-05-24 2022-02-09 루비우스 테라퓨틱스, 아이엔씨. 탈핵 적혈구를 생성하는 방법
GB201908612D0 (en) * 2019-06-17 2019-07-31 Ge Healthcare Bio Sciences Ab A method for separating biomolecules
WO2020257335A1 (en) * 2019-06-17 2020-12-24 Deka Products Limited Partnership System and method for centralized fluid management and culture control
WO2021008571A1 (zh) * 2019-07-16 2021-01-21 信达生物制药(苏州)有限公司 高密度连续接种的细胞培养方法及其应用
EP3831924A1 (en) * 2019-12-03 2021-06-09 Sartorius Stedim Data Analytics AB Adapting control of a cell culture in a production scale vessel with regard to a starting medium
CN119452072A (zh) * 2022-06-28 2025-02-14 美国安进公司 用于治疗性产品制造的灵活的设施配置
IL318802A (en) * 2022-09-06 2025-04-01 Amgen Inc Large-scale bioreactor system and method
JP2026508932A (ja) * 2023-03-13 2026-03-13 アムジエン・インコーポレーテツド シードトレイン最適化のためのシステム及び方法
WO2026033566A2 (en) 2024-08-09 2026-02-12 Omnibrx Biotechnologies Private Limited A multistage bioreactor system and method thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2058992C1 (ru) * 1993-07-14 1996-04-27 Антипин Георгий Васильевич Способ получения кормового белка и устройство для его осуществления
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
RU2215748C2 (ru) * 1999-04-09 2003-11-10 Сентро Де Инмунология Молекулар Способ получения рекомбинантного эритропоэтина человека и полученный эритропоэтин, фармацевтическая композиция
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
ES2276853T3 (es) * 2000-12-20 2007-07-01 Bayer Pharmaceuticals Corporation Dispositivo y procedimiento para expansion en serie de semillas de celulas de mamifero.
JP2005509406A (ja) * 2001-05-09 2005-04-14 バイエル・フアーマシユーチカルズ・コーポレーシヨン 哺乳動物細胞株のための低温保存袋アセンブリー
KR100909316B1 (ko) 2001-08-31 2009-07-24 바이엘 헬스케어 아게 고세포밀도 발효를 수행하기 위한 유닛 및 방법
HUP0402158A2 (hu) 2001-10-02 2005-01-28 Novo Nordisk Health Care Ag Rekombináns fehérjék előállítási eljárása eukarióta sejtekben
AU2002348151A1 (en) 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
US6953692B2 (en) * 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US20050019914A1 (en) 2003-07-24 2005-01-27 Aventis Pharma Deutschland Gmbh Perfusion process for producing erythropoietin
DE102005007512A1 (de) 2004-02-20 2005-09-08 CESCO Bioengineering Co., Ltd., Chutung Vorrichtung und Verfahren zum Präparieren und Kultivieren von Zellen
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
AU2005287162B2 (en) 2004-09-16 2010-12-23 Becton, Dickinson And Company Perfusion bioreactor for culturing cells
EP1807101B1 (en) 2004-09-30 2016-04-13 Bayer Healthcare LLC Devices and methods for integrated continuous manufacturing of biological molecules
ES2662589T3 (es) 2005-06-15 2018-04-09 Zhejiang Jinyishengshi Bioengineering Co., Ltd. Recipientes para cultivo en suspensión
WO2006138143A1 (en) 2005-06-15 2006-12-28 Amprotein Corporation Suspension culture vessels
WO2008024769A2 (en) 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
WO2008073620A2 (en) 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
WO2008106515A1 (en) 2007-02-27 2008-09-04 The Board Of Trustees Of The University Of Illinois Insert device for multiwell plate
SI2126093T1 (sl) * 2007-03-02 2013-01-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Izboljšanje priprave proteinov
AU2007351639B2 (en) 2007-04-17 2012-12-13 Sartorius Stedim Chromatography Systems Ltd. Method and device for continuous membrane adsorption
US9109193B2 (en) 2007-07-30 2015-08-18 Ge Healthcare Bio-Sciences Corp. Continuous perfusion bioreactor system
ES2657055T3 (es) 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
WO2009034186A2 (en) 2007-09-13 2009-03-19 Helmholtz-Zentrum für Infektionsforschung GmbH Process for cell cultivation
US20090233334A1 (en) 2008-03-11 2009-09-17 Excellgene Sa Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale
DE102008019691A1 (de) 2008-04-15 2009-10-29 Technische Universität Ilmenau Teilaktives mikrofluidisches System für die 3D-Zellkultivierung sowie Verfahren zu dessen Perfusion
US20100076380A1 (en) 2008-06-16 2010-03-25 Amprotein Corporation Bioreactors
WO2010120514A2 (en) 2009-03-31 2010-10-21 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
CN107043703B (zh) * 2009-07-06 2020-03-27 弗·哈夫曼-拉罗切有限公司 真核细胞的培养方法
EP2649016B1 (en) 2010-12-06 2020-06-10 Pall Corporation Continuous processing methods for biological products
EP4036207B1 (en) 2011-01-17 2025-10-22 F. Hoffmann-La Roche AG Use of a separation apparatus in a seed train
US9163089B2 (en) 2011-05-12 2015-10-20 Probiogen Ag Enhancement of protein production yield mediated by a fast shuttling CDC42 GTPase
CA2838695C (en) 2011-07-01 2017-02-14 Amgen Inc. Mammalian cell culture
AR089231A1 (es) * 2011-12-15 2014-08-06 Amgen Inc Metodo de floculacion
US20150004686A1 (en) 2012-02-02 2015-01-01 Corning Incorporated Automatic continuous perfusion cell culture microplate consumables
SG10201607963SA (en) 2012-04-01 2016-11-29 Emd Millipore Corp Cell culture and gradient migration assay method and devices
AU2013334602B2 (en) 2012-10-23 2018-05-31 Genzyme Corporation Perfusion culturing methods and uses thereof
AU2014218715B2 (en) 2013-02-22 2019-12-12 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
MX367025B (es) 2013-02-22 2019-08-02 Genzyme Corp Metodos de cultivo por perfusion con microportadores y usos de los mismos.
US9650412B2 (en) 2013-03-08 2017-05-16 Genzyme Corporation Integrated continuous manufacturing of therapeutic protein drug substances
EP4008768A1 (en) 2013-03-15 2022-06-08 Genzyme Corporation High-density cell banking methods
KR102749545B1 (ko) 2013-09-16 2025-01-07 젠자임 코포레이션 세포 배양물을 가공하는 방법 및 시스템
US20160289633A1 (en) 2013-12-20 2016-10-06 Biogen Ma Inc. Use of Perfusion Seed Cultures to Improve Biopharmaceutical Fed-Batch Production Capacity and Product Quality
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
CN106687575B (zh) 2014-06-04 2021-04-30 美国安进公司 用于收获哺乳动物细胞培养物的方法
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TW202246486A (zh) 2014-06-09 2022-12-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
CN104450597B (zh) 2014-12-10 2020-07-28 青岛农业大学 一种石油降解菌固体菌剂的制备方法及由其制备的固体菌剂修复石油污染的土壤的方法
MX383857B (es) 2014-12-22 2025-03-14 Genzyme Corp Métodos de cultivo de una célula de mamífero.

Also Published As

Publication number Publication date
RU2016151316A3 (es) 2018-11-15
CA2951551C (en) 2023-02-28
JP2022120031A (ja) 2022-08-17
IL281626B (en) 2022-03-01
JP2021019621A (ja) 2021-02-18
AU2021245116B2 (en) 2023-07-27
EP3858983B1 (en) 2025-07-16
HUE047683T2 (hu) 2020-05-28
KR102584375B1 (ko) 2023-09-27
EP3628730A1 (en) 2020-04-01
US10570367B2 (en) 2020-02-25
TW202246486A (zh) 2022-12-01
KR20170015472A (ko) 2017-02-08
CA2951551A1 (en) 2015-12-17
RU2016151316A (ru) 2018-07-10
KR20220098051A (ko) 2022-07-08
EP3858983C0 (en) 2025-07-16
BR112016028891A2 (pt) 2017-08-22
RU2694327C2 (ru) 2019-07-11
EP3152299B1 (en) 2019-11-20
IL249452B (en) 2021-04-29
AU2021245116A1 (en) 2021-10-28
CN106574249A (zh) 2017-04-19
MX2020004073A (es) 2020-07-29
BR112016028891B1 (pt) 2023-04-11
US20150353896A1 (en) 2015-12-10
CY1122803T1 (el) 2021-05-05
MX373323B (es) 2020-05-04
IL249452A0 (en) 2017-02-28
IL290096B2 (en) 2024-04-01
IL281626A (en) 2021-05-31
AU2015274897B2 (en) 2021-11-04
CN111575225A (zh) 2020-08-25
ES3043610T3 (en) 2025-11-25
US20200377850A1 (en) 2020-12-03
CN106574249B (zh) 2020-05-08
DK3152299T3 (da) 2020-02-24
CN111575225B (zh) 2023-09-08
AU2023203734A1 (en) 2023-07-06
WO2015191462A1 (en) 2015-12-17
JP7089000B2 (ja) 2022-06-21
TWI707949B (zh) 2020-10-21
EP3858983A1 (en) 2021-08-04
IL290096A (en) 2022-03-01
EP3152299A1 (en) 2017-04-12
JP6784600B2 (ja) 2020-11-11
JP2017521057A (ja) 2017-08-03
AU2015274897A1 (en) 2017-01-12
SG11201610216UA (en) 2017-01-27
RU2019119708A (ru) 2019-07-03
ES2773630T3 (es) 2020-07-13
KR102416402B1 (ko) 2022-07-04
IL290096B1 (en) 2023-12-01
JP7360504B2 (ja) 2023-10-12
TW202102658A (zh) 2021-01-16
TWI776235B (zh) 2022-09-01
TW201610148A (zh) 2016-03-16

Similar Documents

Publication Publication Date Title
MX2016016301A (es) Procesos de siembra en serie y usos de los mismos.
MX2018003491A (es) Represores de htt y usos de estos.
ECSP18008905A (es) Tricíclicos sustituidos y método para usarlos.
CL2017003404A1 (es) Compuestos antibacterianos
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
MX2017007049A (es) Anticuerpos anti-cd79b y métodos de uso.
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
ECSP17023281A (es) Inhibidores de mk2 y sus usos
UY37523A (es) Anticuerpos anti-ox40 y sus usos
TWD174683S (zh) 戒指
CR20190271A (es) Anticuerpos antitau y métodos de uso
MX2016012880A (es) Cadena j modificada.
MX390849B (es) Anticuerpos antagonistas anti-axl.
MX2016010433A (es) Anticuerpos anti-jagged1 y metodos de uso.
MX2016014247A (es) Conjugados de anticuerpo-farmaco anti-proteina tirosina quinasa 7 (anti-ptk7).
MX2017006283A (es) Peptidos macrociclicos utiles como inmunomoduladores.
CR20160257A (es) Anticuerpos e inmunoconjugados anti-cd33
CR20180605A (es) Anticuerpos anti-cd40 y sus usos
CR20150482A (es) Anticuerpos e inmunoconjugados anti-b7-h4
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
CL2017001661A1 (es) Compuestos biciclicos fusionados para el tratamiento de una enfermedad.
MX2017002469A (es) Composiciones de matrices extracelulares.
BR112016017402A2 (pt) fusões anti-pcsk9~glp-1 e métodos para uso

Legal Events

Date Code Title Description
FG Grant or registration